GP leader hits out at regulator’s demands

December 10, 2007
Sales and Marketing

The chairman of the NHS Alliance has criticised a new report which says GPs are not carrying out 'basic work' …

Eisai gets go ahead for Alzheimer’s appeal

December 10, 2007
Alzheimer's, Eisai, NICE

Eisai is to make one more legal challenge to NICE by taking its case on Alzheimer’s drugs to the Court …

ABPI names new president

December 10, 2007
ABPI

AstraZeneca's Chris Brinsmead has been named as the next president of the ABPI.He will take over from the current ABPI …

Latest news from Datamonitor

December 10, 2007
Research and Development

Adventrx completes enrolment for breast cancer trialAdventrx Pharmaceuticals has completed patient enrolment in its Phase II clinical trial of CoFactor …

Safety first

December 10, 2007
Research and Development, Sales and Marketing clinical trials, drug development, drug safety

There is a tide of change in drug safety within the pharmaceutical industry.  Internal and external forces are pushing drug …

NICE approves Novartis asthma jab

November 30, 2007
Sales and Marketing

NICE has recommended Novartis' injection Xolair for asthma patients whose condition cannot be controlled by conventional first-line treatments. Patients with …

New GP practices for deprived areas

November 30, 2007

Health secretary Alan Johnson has unveiled plans to open 100 new practices in under-doctored areas within the next three years. …

Ezetrol receives NICE approval

November 30, 2007
Sales and Marketing

NICE has approved Ezetrol, the cholesterol-lowering drug marketed by MSD and Schering-Plough. Data shows the drug significantly reduces bad cholesterol …

Divert money from Herceptin, says radiotherapy leader

November 30, 2007
Sales and Marketing

Money currently being spent on Herceptin for breast cancer patients could be better spent on providing radiotherapy, a leader in …

Sanofi and Regeneron sign antibody deal

November 30, 2007
Research and Development

Sanofi-Aventis has increased its stake in Regeneron and will collaborate with the US biotech company on new antibody research.The companies …

Short sighted pharma undermining its own future, says Oxfam

November 30, 2007
Sales and Marketing

Pharmaceutical companies are damaging their businesses by blocking access to drugs for millions of people in the developing world, according …

Wyeth kidney cancer drug approved in Europe

November 29, 2007
Sales and Marketing

Wyeth's orphan cancer drug Torisel has been approved in Europe for difficult to treat cases of advanced renal cell carcinoma.It …

European approval for Merck’s cyanide antidote

November 29, 2007
Sales and Marketing

European regulators have approved Merck Serono's cyanide poisoning cure Cyanokit for use in adults and children. Cyanide poisoning is primarily …

Latest news from Datamonitor

November 29, 2007
Research and Development

Medivir to initiate Phase IIa study of hepatitis CMedivir has announced that a Phase IIa study for its investigational hepatitis …

Do regional marketing teams really work?

November 29, 2007
Sales and Marketing Europe, marketing, regional marketing

 In this feature, we tackle the subject of the regional marketing team and look at a number of issues, including …

Champix linked to depression and suicidal thoughts

November 22, 2007
Sales and Marketing reg, safety

Pfizer has alerted US regulator the FDA to cases of depression and suicidal thoughts in patients taking its smoking cessation …

Pfizer buys immune system specialists Coley

November 22, 2007
Research and Development

Pfizer is to acquire a company developing new drugs that fight diseases by altering the immune system. The company is …

NHS set for major underspend

November 22, 2007

Efforts to save money in the NHS have proved so successful that the health service is set to underspend its …

The Gateway to Local Adoption Series

Latest content